Press Releases Press Releases Year None202420232022202120202019201820172016201520142013201120102009200820072005 April 24, 2024 Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares PDF Version April 17, 2024 Intra-Cellular Therapies Prices Public Offering of Common Stock PDF Version April 16, 2024 Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock PDF Version April 16, 2024 Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder PDF Version March 19, 2024 Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes PDF Version March 6, 2024 Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences PDF Version February 27, 2024 Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference PDF Version February 22, 2024 Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update PDF Version February 8, 2024 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast PDF Version January 2, 2024 Intra-Cellular Therapies to Present at the 42nd Annual J.P. Morgan Healthcare Conference PDF Version Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
April 24, 2024 Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares PDF Version
April 16, 2024 Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock PDF Version
April 16, 2024 Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder PDF Version
March 19, 2024 Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes PDF Version
March 6, 2024 Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences PDF Version
February 27, 2024 Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference PDF Version
February 22, 2024 Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update PDF Version
February 8, 2024 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast PDF Version
January 2, 2024 Intra-Cellular Therapies to Present at the 42nd Annual J.P. Morgan Healthcare Conference PDF Version
